32 results
Central Retinal Artery Occlusion (CRAO) vs Central Retinal Vein Occlusion (CRVO) - A Comparison Table

Clinical Features,
- A Comparison Table ... Diagnosis and Treatment ... #CRAO #CRVO #Ophthalmology ... Vein #Comparison #Table
Drug Treatment of Anaphylaxis and Allergic Reactions
First-Line Therapy 
 - Epinephrine 
 - Oxygen 
 -
Drug Treatment of ... fluids: NS or LR Second-Line ... #Pharmacology #Table
Hordeolum vs Chalazion

Hordeolum (Stye):
 • Location: Most commonly found at or near an eyelash follicle
 •
, swelling • Treatment ... painless lump • Treatment ... Diagnosis #Management #Ophthalmology ... Chalazion #Comparison #Table
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
Drugs Used for the Treatment ... Editor Note (from ophthalmology ... HCQ treatment would ... of short term treatment ... #Pharmacology #Table
Horner's Syndrome on Physical Exam

A 75yoF was referred in for facial swelling and eyelid changes 1
or induced by treatment ... The video highlights ... Syndrome #clinical #video ... #ophthalmology
â–ş
Pain Assessment and Management Initiative (PAMI) - Nonpharmacologic Interventions (pediatric and adult)
Physical (Sensory) Interventions
 - Comfort
- Hot or Cold treatments ... movies, games, videos ... Interventions #Table
Anterior Non-necrotizing Scleritis - Slit Lamp Ocular Examination

This 57 yo WM reported to clinic complaining of
the patient was sent ... systemic workup and treatment ... Scleritis #clinical #video ... #ophthalmology
â–ş
Retinal Vasculitis in Takayasu’s Arteritis- ...Ophthalmologic examination revealed severe impairment, with perception of only light in
Arteritis- ...Ophthalmologic ... Panel A, and see Video ... and initiated treatment ... Panel B, and see Video ... See source for videos
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Dosing: 250 mcg tablet ... recommendations for the treatment ... Second if patient ... This second group
Long-Acting Injectable (LAI) - Atypical Antipsychotics 
INVEGA TRINZA 3 MONTHS 
ARISTADA 2 MONTHS 
INVEGA 1 MONTH
SUSTENNA
otherwise known as second-generation ... are used in the treatment ... Pharmacists are able